Attached files
| file | filename |
|---|---|
| 10-K - ELITE PHARMACEUTICALS INC /NV/ | v190023_10k.htm |
| EX-21 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex21.htm |
| EX-23.2 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex23-2.htm |
| EX-31.1 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex31-1.htm |
| EX-23.1 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex23-1.htm |
| EX-32.2 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex32-2.htm |
| EX-31.2 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex31-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Elite Pharmaceuticals, Inc. (the “Company”)
on Form 10-K for the year ended March 31, 2010 filed with Securities and
Exchange Commission (the “Report”), I, Jerry Treppel, Chairman of the Board of
Directors and Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:
|
|
1.
|
The
Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934;
and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the consolidated financial condition of the Company as of the
dates presented and the consolidated result of operations of the Company
for the periods presented.
|
|
Date:
July 7, 2010
|
/s/ Jerry Treppel
|
|
|
Jerry
Treppel, Chairman of the Board and Chief Executive Officer
|
This
certification has been furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
A signed
original of this written statement required by Section 906 has been provided to
Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.